Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment
Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment
复制标题
DOI:
10.1016/j.parkreldis.2012.11.012
复制
发表时间:
2013-03-01
影响因子:
4.1
通讯作者:
Wang, Lijuan
中科院分区:
文献类型:
--
作者:
Nie, Kun;Zhang, Yuhu;Wang, Lijuan
Background: The mild cognitive impairment in Parkinson's disease (PD-MCI) has received increasing attention, of which the diagnosis is challenging. To analyze the possible biomarkers for the early diagnosis, we investigated the metabolite changes in different brain regions of PD-MCI patients as well as appropriate controls by proton magnetic resonance spectroscopy (MRS).Methods: The metabolism in the occipital lobe, posterior cingulate, substantia nigra and basal ganglia was studied in 66 PD-MCI patients, 70 cognitively normal PD patients (PD-CN) and 74 healthy controls.Results: The N-acetylaspartate to creatine (NAA/Cr) ratio in the occipital lobe in PD-MCI patients was lower than that in healthy controls (P < 0.05). In contrast, the choline to creatine ratio in the posterior cingulate was higher in PD-MCI patients than in controls or PD-CN patients (both P < 0.05). No significant metabolite difference in the substantia nigra and basal ganglia was found. Furthermore, the decreases of the ratios of NAA/Cr in the occipital lobe were associated with PD-CN (P < 0.05) and PD-MCI (P < 0.0001) while the increase in the ratio of Cho/Cr in the posterior cingulate was associated with PD-MCI (P